London Company Large Cap Sold Its Holdings in Bruker Corporation (BRKR) in Q3

The London Company, an investment management company, released “The London Company Large Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities continued their rally in the third quarter, driven by the Fed rate cut, solid corporate earnings, and enthusiasm around AI. The economy retained most of its momentum from the second quarter, even though the economic data released during the third quarter was mixed. The portfolio returned 6.3% (6.2%, net) during the quarter compared to an 8.0% gain for the Russell 1000 Index. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2025.

In its third-quarter 2025 investor letter, The London Company Large Cap Strategy highlighted stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) focuses on the development and manufacturing of scientific instruments and analytical and diagnostic solutions. The one-month return of Bruker Corporation (NASDAQ:BRKR) was 6.17%, and its shares lost 34.78% of their value over the last 52 weeks. On November 3, 2025, Bruker Corporation (NASDAQ:BRKR) stock closed at $38.71 per share, with a market capitalization of $5.873 billion.

The London Company Large Cap Strategy stated the following regarding Bruker Corporation (NASDAQ:BRKR) in its third quarter 2025 investor letter:

“Exited: Bruker Corporation (NASDAQ:BRKR) – We elected to sell our position in BRKR after shares significantly underperformed the broader market since our purchase in 2024. Headwinds from weak pharma spending, possible cuts to NIH and academic funding, and tariff concerns may continue. The stock hit our soft stop loss, and with no insider purchases or accelerated buybacks from the company, we elected to exit the position and fund a higher-conviction idea.”

Bruker Corp. (BRKR) Dismal Q2 Earnings Weighs On Sentiment

Bruker Corporation (NASDAQ:BRKR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. According to our database, 42 hedge fund portfolios held Bruker Corporation (NASDAQ:BRKR) at the end of the second quarter, up from 40 in the previous quarter.  While we acknowledge the risk and potential of Bruker Corporation (NASDAQ:BRKR) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Bruker Corporation (NASDAQ:BRKR) and that has 10,000% upside potential, check out our report about this cheapest AI stock.

In another article, we covered Bruker Corporation (NASDAQ:BRKR) and shared the list of best medical device stocks to invest in. In addition, please check out our hedge fund investor letters Q3 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.